Around 53% and 20% of patients with sporadic MTC carry mutually exclusive somatic mutations of the rearranged during transfection (RET) and rat sarcoma virus (RAS) genes, respectively. This evidence concerns the gene RET and medullary thyroid gland carcinoma.